TIFFANY ALI: Open Payments
NPI 1083090294 · WEST AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 46 payments from 15 companies in 2025. Trend: 2023 $145 · 2024 $681 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $327 |
| AstraZeneca Pharmaceuticals LP | 7 | $258 |
| Sumitomo Pharma America, Inc. | 5 | $131 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Boston Scientific Corporation | 1 | $35 |
| Abbott Laboratories | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $29 |
Products named: OTEZLA, BREZTRI, GEMTESA, REPATHA, AIRSUPRA, KRYSTEXXA, WATCHMAN Access System, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
